{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:09:56Z","timestamp":1777590596131,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T00:00:00Z","timestamp":1599004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jdcr.2020.08.041","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T11:36:07Z","timestamp":1600083367000},"page":"1342-1344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary cutaneous peripheral T-cell lymphoma, not otherwise specified with mammalian target of rapamycin mutation: A novel finding for targeted treatment"],"prefix":"10.1016","volume":"6","author":[{"given":"Carlo","family":"De la Sancha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Callie","family":"Burgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Warren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utpal","family":"Dav\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Nassiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.jdcr.2020.08.041_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2217\/epi-2018-0195","article-title":"BCOR involvement in cancer","volume":"11","author":"Astolfi","year":"2019","journal-title":"Epigenomics"},{"issue":"5","key":"10.1016\/j.jdcr.2020.08.041_bib2","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/bjh.14529","article-title":"m-TOR inhibitors and their potential role in haematological malignancies","volume":"177","author":"Calimeri","year":"2017","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jdcr.2020.08.041_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/sci.2016.07.02","article-title":"Will targeting PI3K\/Akt\/mTOR signaling work in hematopoietic malignancies?","volume":"3","author":"Gao","year":"2016","journal-title":"Stem Cell Investigation"},{"issue":"3","key":"10.1016\/j.jdcr.2020.08.041_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2015-02-629543","article-title":"The mTORC1 inhibitor everolimus has antitumor activity in\u00a0vitro and produces tumor responses in patients with relapsed T-cell lymphoma","volume":"126","author":"Witzing","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jdcr.2020.08.041_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.24300","article-title":"TAK-228 (formerly MLN0128), an investigational oral dual TORC1\/2 inhibitor: a phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenstr\u00f6m's macroglobulinemia","volume":"91","author":"Ghobrial","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jdcr.2020.08.041_bib6","series-title":"World Health Organization Classification of Tumours: Pathology and Genetics of Skin Tumours","author":"Philip","year":"2006"},{"key":"10.1016\/j.jdcr.2020.08.041_bib7","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1182\/blood-2002-07-1960","article-title":"Peripheral T-cell lymphomas unspecified presenting in the skin: analysis of prognostic factors in a group of 82 patients","volume":"102","author":"Bekkenk","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jdcr.2020.08.041_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/cup.12409","article-title":"CD8-positive peripheral T-cell lymphoma with aberrant expression of CD20 and concurrent in situ follicular lymphoma","volume":"42","author":"Amaia","year":"2015","journal-title":"J Cutan Pathol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620306585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512620306585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:22:46Z","timestamp":1762474966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512620306585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":8,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2352512620306585"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.08.041","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary cutaneous peripheral T-cell lymphoma, not otherwise specified with mammalian target of rapamycin mutation: A novel finding for targeted treatment","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2020.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc. Published by Elsevier, Inc.","name":"copyright","label":"Copyright"}]}}